Conference call interim report

Invitation to attend XVIVO Perfusion’s conference call regarding presentation of
the interim report for the period January – March, 2014. The presentation will
be held in English.
Time: Wednesday, April 23, 2014 at 2.00 p.m. CET

Registration can preferably be done in advance under the following link:
https://engage.vevent.com/rt/xvivoperfusion~1319928

or shortly before time of the conference starts on:
Sweden dial in number: +46 (0)8-503 364 34
International dial in number: +44 (0) 1452 555566
Conference name: XVIVO Perfusion, conference ID: 1319928

Participants from XVIVO Perfusion:
Magnus Nilsson, CEO
Christoffer Rosenblad, CFO

The press release for XVIVO Perfusion’s interim report for the period January –
March, 2014 will be released before the conference call April 23, 2014.

Before the conference call, slides will be available at the company web page,
www.xvivoperfusion.com/corporate/.

April 14, 2014
Gothenburg
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +46 31 788 21 59,
christoffer.rosenblad@xvivoperfusion.com
For further information on XVIVO Perfusion’s business, please refer to the
company’s website, www.xvivoperfusion.com

This is a translation of the Swedish version of the press release. When in
doubt, the Swedish wording prevails.
________________________________________________________________________________
_ 
_____________________________________

XVIVO Perfusion AB is a medical technology company which develops solutions and
systems for assessing and preserving organs outside the body and for selecting
usable organs and maintaining them in optimal condition pending transplantation.
The company is headquartered in Gothenburg, Sweden, and has one office in the
USA. The XVIVO share is listed on NASDAQ OMX First North and has the ticker
symbol XVIVO. More information can be found on the website
www.xvivoperfusion.com. The Certified Adviser is Redeye, www.redeye.se.
________________________________________________________________________________
_ 
_____________________________________

XVIVO Perfusion AB (publ), Box 53015, SE-400 14 Göteborg. Corporate identity
number 556561-0424.
Tel: 46 31 788 21 50. Fax: 46 31 788 21 69.
E-mail: info@xvivoperfusion.com. Website: www.xvivoperfusion.com